<rt id="kiprx"></rt>

<big id="kiprx"><progress id="kiprx"></progress></big>
<output id="kiprx"><big id="kiprx"></big></output>
<blockquote id="kiprx"></blockquote>
亚洲中文久久久精品无码,亚洲av激情五月性综合,国产精品美女久久久久久麻豆,日韩日韩日韩日韩日韩,亚洲国产精品无码久久久秋霞1,中文字幕一卡二卡三卡,国产精品理论片在线观看,亚洲熟女综合色一区二区三区
您好!歡迎訪問上海起發實驗試劑有限公司網站!
全國服務咨詢熱線:

15921799099

當前位置:首頁 > 產品中心 > 代理品牌 > 國際品牌 > biomonitor 特約總代理

biomonitor 特約總代理

簡要描述:biomonitor代理,biomonitor上海代理,biomonitor北京代理,biomonitor總代理,biomonitor一級代理,biomonitor特約代理
上海起發實驗試劑有限公司biomonitor專業代理,具體產品信息歡迎電詢:4006551678

  • 產品型號:
  • 廠商性質:代理商
  • 更新時間:2026-01-04
  • 訪  問  量:3138

詳細介紹

世界*實驗材料供應商 Biomonitor正式授權上海起發為其中國代理, Biomonitor在一直是行業的*,一直為廣大科研客戶提供zui為優質的產品和服務,上海起發一直秉承為中國科研客戶帶來的產品,的服務,簽約 Biomonitor就是為了給廣大科研客戶帶來更加*的產品和服務,您的滿意將是我們zui大的收獲

 Biomonitor中國代理, Biomonitor上海代理, Biomonitor北京代理,Biomonitor廣東代理, Biomonitor江蘇代理Biomonitor 湖北代理,Biomonitor天津,Biomonitor黑龍江代理,Biomonitor內蒙古代理,Biomonitor吉林代理,Biomonitor福建代理, Biomonitor江蘇代理, Biomonitor浙江代理, Biomonitor四川代理,

 

丹麥Biomonitor www.biomonitor.dk
Biomonitor A/S 是一家位于丹麥的未上市公司,創立于2003年,由丹麥 Sunstone Capital 提供資助。該公司是開發創新型可靠檢測技術并將這些測試融入大型*患者監測計劃的公司之一。除了面向多發性硬化患者的監測計劃之外,該公司還為接受抗 TNF 藥物治療的患者提供實驗室測試服務(藥物的循環水平和抗藥抗體的監測),并作為一家專業化合同研究組織 (CRO) 為藥物和生物技術行業的多種生物藥物開發計劃提供支持。Biomonitor Limited 是 Biomonitor A/S 的全資子公司,位于愛爾蘭戈爾韋,是一家獲得 ISO 認證的生產機構。

 丹麥Biomonitor

Biomonitor A/S is a privay held Danish company founded in 2003 and funded by Sunstone Capital, Denmark. The company is among the leaders in developing innovative, reliable assay technologies and incorporating these tests into large and comprehensive patient-monitoring programs. In addition to monitoring programs for MS patients, the company offers laboratory-testing services for patients on anti-TNF drug therapy (both circulating levels of drug and detection of ADAs, and, as a specialized CRO, supports the pharma and biotech industry in their drug-development programs for many classes of biological drugs. Biomonitor Limited is Biomonitor A/S’s wholly owned subsidiary located in Galway, Ireland and is an ISO-certified manufacturing facility.

Biomonitor was founded in 2003 by Professor Klaus Bendtzen and Arsalan Kharazmi as a spinout from the University of Copenhagen and has since its inception grown rapidly.

The foundation of the company is based on Professor Klaus Bendtzen’s many years of experience from his research work at the Copenhagen University Hospital on inflammation and immunology. Prof. Klaus Bendtzen discovered through his work how some patients form antibodies against those proteins and peptides that are used in biopharmaceutical products for the treatment of a range of chronic diseases. Antibodies can neutralize the biopharmaceuticals that patients receive and patients with antibodies thereby do not or only marginally benefit from such treatments so it became crucial to develop methods to monitor biopharmaceuticals.

Biopharmaceutical treatments are very costly and potentially dangerous. Consequently, it makes good sense to monitor patients so that the drugs can be tailored to the individual patient and so that physicians early on can deal with patients who develop antibodies. By doing this, patients, society and insurance companies can save tremendous amount of resources and the patient can be relieved from a treatment that does not work as designed. Most biopharmaceutical treatments are relatively new, and Biomonitor is one of the leading companies in the field, which monitors these therapies.

In November 2008 Biomonitor acquired Neutekbio Ltd. With its proprietary platform of products based on reporter gene technology and developed cell-based assays and kits called iLite™, Neutekbio Ltd. complements Biomonitor’s offerings in assays for patient monitoring and biopharmaceutical drug development programs. The discovery research is performed through a collaborative research and development agreement with the Laboratory of Viral Oncology (The Centre National Recherché Scientifique) in the Institute Andre Lwoff, Villejuif, France. These research programs have been carried out under the direction of Dr. Michael Tovey, an international leader in cytokine research and interferon therapy.

 

我們公司zui大優勢是*的采購,

1:基本什么都能進口,血清,抗體,耗材,還有部分限制進口的,

2:貨品全,現經營過700多個品牌,基本所有生物試劑耗材都可以進口,特別是冷偏的產品那就更有優勢,

3:提供加急服務,一般1-2周到貨,超過時限加急費全免

4:價格公道,絕大部分價格有優勢,當然不能保證100%產品都是,因為意味著沒有服務.

5:良好的信譽,大部分客戶我們提供貨到付款服務,客戶包括清華,北大 交大 復旦,中山等100多所大學,ROCHE,阿斯利康,國藥 ,fisher等500多家公司

6:我們還是Santa,Advanced Biotechnologies Inc, Biomonitor,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, GePromegaridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等幾十家國外公司授權代理。
7:我們還是invitrogen,qiagen,Midland BioProducts Corporationam,sigma;Promega,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發,歡迎合作。

上海起發實驗試劑有限公司
:楊建輝
400
辦公:
*8006

企業:
:http://www.qfbio。。com/
地址:上海市浦東新區晨陽路225弄東方現代商業廣場46303(近東亭路

 

產品咨詢

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7
上海起發實驗試劑有限公司
地址:上海浦東川沙鎮川沙路6619號上海起發實驗試劑有限公司
郵箱:xs1@78bio.com
傳真:021-50724961
關注我們
歡迎您關注我們的微信公眾號了解更多信息:
歡迎您關注我們的微信公眾號
了解更多信息
主站蜘蛛池模板: 久久99色综合| 亚洲欧美日韩综合区| 黄色三级亚洲男人的天堂| 亚洲另类激情专区小说图片| 天天躁日日躁狠狠很躁| 色综合久88| 欧美亚洲国产精品久久| 国产精品午夜福利视频234区 | 国产在线自在拍91精品黑人| 天天综合成人| 国产乱人伦无无码视频试看| 2020无码专区人妻系列日韩| 国产精品色一区二区三区| 日韩中文字幕av| 日韩中文字幕高清有码| 精品国产中文字幕av| 国产迷姦播放在线观看| 狠狠躁夜夜躁人人爽天天5| 亚洲人成网站免费播放| 99久久精品久久久久久婷婷| 精品国产杨幂在线观看福利| 欧美精品99无码一区二区| 国产免费一级高清淫日本片| 手机看片福利一区二区三区| 午夜免费福利小电影| 免费一级黄色好看的国产| 一区二区日本在线| 色一情一区二区三区四区| 陆丰市| 国产农村妇女毛片精品久久| 亚洲熟妇国内久久精品| 国产老女人免费观看黄A∨片 | 欧美成人影院亚洲综合图| 成人亚洲色| 国产在线精品福利91香蕉| 夜夜撸天天操| 国产精品白丝喷水在线观看| 热久久99精品这里有精品 | 国产乱老熟女乱老熟女视频| 国产精品免费看久久久| 日韩A人毛片精品无人区乱码|